Zurück zum Zitat Puzanov I, Diab A, Abdallah K, Bingham CO, Brogdon C, Dadu R, Hamad L, Kim S, Lacouture ME, LeBoeuf NR, Lenihan D, Onofrei C, Shannon V, Sharma R, Silk AW, Skondra D, Suarez-Almazor ME, Wang Y, Wiley K, Kaufman HL, Ernstoff MS, Anderson J, Arrindell D, Andrews S, Ballesteros J, Boyer J, Chen D, Chonzi D, Cotarla I, Cunha R, Davies M, Dawson M, Dicker A, Eifler L, Ferguson A, Ferlini C, Frankel S, Go W, Gochett C, Goldberg J, Goncalves P, Goswami T, Gregory N, Gulley JL, Hayreh V, Helie N, Holmes W, Hsu J-Y, Ibrahim R, Larocca C, Lehman K, Ley-Acosta S, Lambotte O, Luke J, McClure J, Michelon E, Nakamura M, Patel K, Piperdi B, Rasheed Z, Reshef D, Riemer J, Robert C, Sarkeshik M, Saylors A, Schreiber J, Shafer-Weaver K, Sharfman W, Sharon E, Sherry R, Simonson C, Thomas C, Thompson JA, Trehu E, Tresnan D, Turner M, Wariabharaj D, Waxman I, Wood L, Zhang L, Zheng P, on behalf of the Society for Immunotherapy of Cancer Toxicity Management Working G (2017) Managing toxicities associated with immune checkpoint inhibitors: consensus recommendations from the society for immunotherapy of cancer (SITC) toxicity management working group. J Immuno Ther Cancer 5(1):95. https://doi.org/10.1186/s40425-017-0300-zCrossRef
Puzanov I, Diab A, Abdallah K, Bingham CO, Brogdon C, Dadu R, Hamad L, Kim S, Lacouture ME, LeBoeuf NR, Lenihan D, Onofrei C, Shannon V, Sharma R, Silk AW, Skondra D, Suarez-Almazor ME, Wang Y, Wiley K, Kaufman HL, Ernstoff MS, Anderson J, Arrindell D, Andrews S, Ballesteros J, Boyer J, Chen D, Chonzi D, Cotarla I, Cunha R, Davies M, Dawson M, Dicker A, Eifler L, Ferguson A, Ferlini C, Frankel S, Go W, Gochett C, Goldberg J, Goncalves P, Goswami T, Gregory N, Gulley JL, Hayreh V, Helie N, Holmes W, Hsu J-Y, Ibrahim R, Larocca C, Lehman K, Ley-Acosta S, Lambotte O, Luke J, McClure J, Michelon E, Nakamura M, Patel K, Piperdi B, Rasheed Z, Reshef D, Riemer J, Robert C, Sarkeshik M, Saylors A, Schreiber J, Shafer-Weaver K, Sharfman W, Sharon E, Sherry R, Simonson C, Thomas C, Thompson JA, Trehu E, Tresnan D, Turner M, Wariabharaj D, Waxman I, Wood L, Zhang L, Zheng P, on behalf of the Society for Immunotherapy of Cancer Toxicity Management Working G (2017) Managing toxicities associated with immune checkpoint inhibitors: consensus recommendations from the society for immunotherapy of cancer (SITC) toxicity management working group. J Immuno Ther Cancer 5(1):95.
https://doi.org/10.1186/s40425-017-0300-zCrossRef